Nymox Pharmaceutical (NYMX) Reports 2012 Financial Results
3/15/2013 11:18:53 AM
HASBROUCK HEIGHTS, N.J., March 15, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the year ended December 31, 2012 prepared in accordance with International Financial Reporting Standards. Nymox reported a net loss of $7,627,589, or $0.23 per share for the year ended December 31, 2012, compared to $9,652,389, or $0.30 per share for same period in 2011. The decrease of the net loss for the year is attributable primarily to a reduction of stock-based compensation charges which were $1,962,085 in 2012 compared to $4,005,404 in 2011. The weighted average number of common shares outstanding for the year ended December 31, 2012 was 33,176,185, compared to 32,711,431 for the same period in 2011.